• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alder Biopharmaceuticals Inc

+ Add to Watchlist

3A9:GR

12.869 EUR 0.016 0.12%

As of 07:38:28 ET on 11/27/2014.

Snapshot for Alder Biopharmaceuticals Inc (3A9)

Open: 13.392 Day's Range: 12.840 - 13.392 Volume: 0
Previous Close: 12.853 52wk Range: 7.169 - 15.702 1-Yr Rtn: -

Stock Chart for 3A9

No chart data available.
  • 3A9:GR 13.392
  • 1D
  • 1M
  • 1Y
12.853
Interactive 3A9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3A9

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 41.7056
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.3850
Est. PEG Ratio -
Market Cap (M EUR) 396.45
Shares Outstanding (M) 30.81
30 Day Average Volume 8
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3A9

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3A9

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

Randall C SchatzmanPresident/CEO/Co-FounderMark J LittonChief Bus Ofcr/Treasurer/Secy
John A LathamChief Scientific Ofcr/Co-FounderLarry K BenedictSenior VP:Finance
More Company Profile & Key Executives for 3A9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil